PATLY.AIApplication
16920267 · TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE
Filed 2020-07-02 · Granted · Patent 11590117 (2023-02-28) The official file ↗The patent and its PDF ↗ · Art unit 1627 · Examiner Sahar Javanmard Typical · CPC A61K 31/454 · Celgene Corporation · Celegene Corporation
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
18.5 mo
to disposition 31.9 mo
Statutes raised
DP
1 actions read